Clinical implication of FDG uptake of bone marrow on PET/CT in gastric cancer patients with surgical resection

doi:10.3748/wjg.v23.i13.2385

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9757)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

654

WORD

260

HTML

5140

Figures (1-3)

625

Tables (1-5)

207

Sum=6886

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1039

Download

1829

Sum=2868

Apr 7, 2017 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (31)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Apr 7, 2017; 23(13): 2385-2395
Published online Apr 7, 2017. doi: 10.3748/wjg.v23.i13.2385

Open in New Tab Full Size Figure Download Figure

Figure 1 F-18 fluorodeoxyglucose positron emission tomography/computed tomography images of a gastric cancer patient with diffusely increased F-18 fluorodeoxyglucose uptake of bone marrow. A: Maximum intensity projection; B and C: Coronal and transaxial PET images; D: Transaxial CT image; E: Fused transaxial PET/CT image of a 71-year-old woman with advanced gastric cancer. Focal intensely increased FDG uptake was observed in the primary tumor lesion of stomach with Tmax of 8.36 (arrow). BM of the patient showed increased FDG uptake with BM SUV of 2.36 and BLR of 1.25. The patient underwent total gastrectomy. The cancer recurred 13.4 mo after the treatment and the patient died 18.5 mo after the operation. PET/CT: Positron emission tomography/computed tomography; FDG: F-18 fluorodeoxyglucose; BM: Bone marrow; BLR: BM-to-liver uptake ratio.

Open in New Tab Full Size Figure Download Figure

Figure 2 F-18 fluorodeoxyglucose positron emission tomography/computed tomography images of a gastric cancer patient with minimally increased F-18 fluorodeoxyglucose uptake of bone marrow. A: Maximum intensity projection; B and C: Coronal and transaxial PET images; D: Transaxial CT image; E: Fused transaxial PET/CT image of a 75-year-old woman with advanced gastric cancer. Focal intensely increased FDG uptake was observed in the primary tumor lesion of stomach with Tmax of 7.57 (arrow). BM SUV and BLR were 1.12 and 0.54, respectively. The patient underwent total gastrectomy. The patient is still alive without cancer recurrence with a follow-up period of 35.5 mo. PET/CT: Positron emission tomography/computed tomography; FDG: F-18 fluorodeoxyglucose; BM: Bone marrow; BLR: BM-to-liver uptake ratio.

Open in New Tab Full Size Figure Download Figure

Figure 3 Kaplan-Meier survival curves for recurrence-free survival and overall survival. A: Recurrence survival curve according to T stage; B: Overall survival curve according to T stage; C: Recurrence-free survival curve according to BLR; D: Overall survival curve according to BLR. BLR: Bone marrow-to-liver uptake ratio.

Citation: Lee JW, Lee MS, Chung IK, Son MW, Cho YS, Lee SM. Clinical implication of FDG uptake of bone marrow on PET/CT in gastric cancer patients with surgical resection. World J Gastroenterol 2017; 23(13): 2385-2395
URL: https://www.wjgnet.com/1007-9327/full/v23/i13/2385.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i13.2385